Blog
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP
  • HEMING GROUP

Company News

Industry News

HEMING GROUP

Jiangxi Provincial Vice Governor Shi Ke visited and investigated Homing Group

2024-01-05

　　At the beginning of the new year, with everything renewed, on the morning of January 4th, Shi Ke, Vice Governor of Jiangxi Province; Wang Haitao, Vice Secretary-General of the Provincial Government; and Liu Xiaohui, Director of the Provincial Administration of Traditional Chinese Medicine, visited Jiangxi Heming Group for a survey. Zhou Mi, Deputy Mayor of Ji'an City; Zou Weimei, County Party Secretary; and Zhao Xiaoming, Chairman of Heming Group; Zeng Xionghui and Chen Zhihong, Vice Presidents of the Group, accompanied them.

　　Shi Ke and his party first visited the Heming Group exhibition hall, where Chairman Zhao Xiaoming introduced the development history of the Heming Group. Jiangxi Heming Pharmaceutical Company was established in Yongfeng in 2012, Jiangxi Heming Pharmaceutical in 2014. In 2019, Chengzhi Yongfeng Pharmaceutical was acquired, followed by the acquisition of Jiangxi Nanchang Pharmaceutical in 2022. Currently, it holds 118 national drug approvals (Guo Yao Zhun Zi), covering various dosage forms such as oral liquids, tablets, granules, capsules, syrups, pastes, and mixtures. Among them, the single product sales of Chengzhi Yongfeng Pharmaceutical's Jubei Mixture exceeded 300 million yuan, and products such as dandelion granules, Huaji oral liquid, and compound loquat syrup are popular in the market and have received consistent praise from patients. Vice Governor Shi Ke gave full affirmation to the development history and achievements of the Heming Group. He also pointed out that past achievements are historical sedimentation, and future efforts should focus on strengthening research and development, innovation, and continuously developing market-oriented products to strive to make the enterprise bigger and stronger.

　　Following this, Shi Ke and his party visited the bird's-eye view map of the Heming Group's Phase II digital technology transformation project. Chairman Zhao Xiaoming briefly introduced the overview of the Phase II project. The project covers an area of 142 mu (approximately 94,667 square meters) with a construction area of 137,000 square meters. Land acquisition, environmental impact assessment, safety assessment, and overall design have been completed. Construction is expected to officially start in March 2024, with a construction and trial production period of approximately 3 years. After completion, the group's sales are expected to exceed 1.5 billion yuan, and taxes will exceed 100 million yuan. Vice Governor Shi Ke was very pleased after hearing the introduction. He suggested that the company extend its industrial chain, such as developing the cultivation of Chinese medicinal materials to drive the common development of the industrial chain. He also hoped that the company would achieve an output value of 3 billion yuan within five to eight years and strive for a listing on the main board as soon as possible.

　　Finally, Shi Ke and his party visited the Jiangxi Provincial Children's Hospital and the Jiangxi Maternal and Child Health Care Hospital preparation center of the Heming Group. Vice President Chen Zhihong gave a brief report. Upon learning that the Heming Group had pioneered hospital-enterprise cooperation, Shi Ke once again gave full affirmation and clearly pointed out that the enterprise must ensure product quality, drug safety and effectiveness, and provide high-quality services to medical institutions.

　　Chairman Zhao Xiaoming, on behalf of the Heming Group, expressed gratitude to Vice Governor Shi Ke and his party for their concern for the enterprise and stated that they would certainly do their best to fulfill the leadership's requirements and contribute to the development of the province's pharmaceutical industry.

Previous Page

The first medical industry packaging skills competition was grandly held at He Ming Pharmaceutical

Good news! Congratulations to Mr. Zhao Xiaoming, Chairman of Heping Group, and Ms. Chen Zhihong, Vice President of Heping Group, on being recognized as high-level talents at the municipal level.

Next Page

Previous Page:

The first medical industry packaging skills competition was grandly held at He Ming Pharmaceutical

Next Page:

Good news! Congratulations to Mr. Zhao Xiaoming, Chairman of Heping Group, and Ms. Chen Zhihong, Vice President of Heping Group, on being recognized as high-level talents at the municipal level.